BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2005
 |  BioCentury  |  Product Development

No Entry

No Entry

Company Product Target Status Administration
Coreceptor inhibitors
GlaxoSmithKline Aplaviroc (873140)...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >